beta-lapachone has been researched along with Ototoxicity in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
Ototoxicity: Damage to the EAR or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, HS | 1 |
| Kim, YR | 1 |
| Lee, IK | 1 |
| Kim, UK | 1 |
| Baek, JI | 1 |
| Lee, KY | 1 |
1 other study available for beta-lapachone and Ototoxicity
| Article | Year |
|---|---|
KL1333, a derivative of β-lapachone, protects against cisplatin-induced ototoxicity in mouse cochlear cultures.
Topics: Animals; Antioxidants; Apoptosis; Cisplatin; Cochlea; Hair Cells, Auditory; Immunohistochemistry; Me | 2020 |